ScienceDex / Researcher record
Ethan Dmitrovsky
- Leidos Biomedical Research, Inc. (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 1% Funded
- Early Career
NIH Funding · FY2025
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $17.5M in linked award amounts across 1 award record · Award-linked rank #151.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2025 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 77885223Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award records by amount
NIH award records listing Ethan Dmitrovsky as a PI. Multi-PI records show the full award amount for context.
- 75N91019D00024-P00008-759102000026-1N01Contact PIDEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS$17.5Maward amount
Award organization
Organizations that administered FY2025 awards listing Ethan Dmitrovsky as a PI.
FY2025 award administered by Leidos Biomedical Research, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardLeidos Biomedical Research, Inc.
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025$10M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #151
- 2025Entered Top 25% NationallyRanked #151
- 2025Entered Top 10% NationallyRanked #151
- 2025Entered Top 5% NationallyRanked #151
- 2025Entered Top 1% NationallyRanked #151